* Phibro Animal Health Corp PAHC.OQ PAHC.O is expected
to show
a rise in quarterly revenue when it reports results on August
28 for the period ending June 30 2024
* The Teaneck New Jersey-based company is expected to
report a
3.2% increase in revenue to $263.245 million from $255 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Phibro Animal Health
Corp is
for earnings of 33 cents per share.
* The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Phibro
Animal
Health Corp is $13.00, below its last closing price of $20.94.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 0.29 0.29 0.31 Beat 6.9
Dec. 31 0001 0.29 0.28 0.33 Beat 18
Sep. 30 2023 0.23 0.23 0.14 Missed -39.1
Jun. 30 2023 0.39 0.38 0.38 Met -1.1
Mar. 0.33 0.34 0.29 Missed -13.4
31 2023
Dec. 31 2022 0.30 0.30 0.34 Beat 12.2
Sep. 30 2022 0.27 0.27 0.21 Missed -20.9
Jun. 30 2022 0.38 0.38 0.26 Missed -32.1
This summary was machine generated August 26 at 20:07 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)